AR and COVID-19: We suggest that sex should be taken into account when designing and analyzing clinical trials in both animal and human studies in SARS-CoV-2 infection and that sex differences may reveal novel therapeutic and interventional approaches such as estrogen-related compounds and androgen receptor antagonists in the treatment of patients with COVID-19.